We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
DoubleVerify
DV
$2.11B
| $344K | ﹤0.01% |
31,780
-1,212,899
| -97% | -$12.5M |
2025 Q4
2 quarters
|
|
2577
Euroseas
ESEA
$462M
| $344K | ﹤0.01% |
+5,179
| New | +$356K |
2026 Q2
0 quarters
|
|
2578
PUT
Comcast
CMCSA
$84.1B
| $344K | ﹤0.01% |
14,000
-270,700
| -95% | -$6.99M |
2021 Q4
18 quarters
|
|
2579
Host Hotels & Resorts
HST
$17.7B
| $343K | ﹤0.01% |
+14,449
| New | +$323K |
2026 Q2
0 quarters
|
|
2580
PennyMac Mortgage Investment
PMT
$688M
| $340K | ﹤0.01% |
30,141
-11,454
| -28% | -$126K |
2025 Q2
4 quarters
|
|
2581
CTS Corp
CTS
$1.79B
| $339K | ﹤0.01% |
+5,197
| New | +$312K |
2026 Q2
0 quarters
|
|
2582
Tenet Healthcare
THC
$21.2B
| $338K | ﹤0.01% |
1,807
+644
| +55% | +$118K |
2024 Q3
7 quarters
|
|
2583
CALL
EOG Resources
EOG
$81.4B
| $337K | ﹤0.01% |
2,600
-10,100
| -80% | -$1.38M |
2025 Q4
2 quarters
|
|
2584
Anterix
ATEX
$1.61B
| $335K | ﹤0.01% |
+3,254
| New | +$191K |
2026 Q2
0 quarters
|
|
2585
State Street SPDR Portfolio S&P 500 ETF
SPYM
$182B
| $334K | ﹤0.01% |
+3,797
| New | +$324K |
2026 Q2
0 quarters
|
|
2586
CALL
KE Holdings
BEKE
$19.3B
| $331K | ﹤0.01% |
22,800
| – | – |
2025 Q2
4 quarters
|
|
2587
Colony Bankcorp
CBAN
$430M
| $330K | ﹤0.01% |
16,449
+4,802
| +41% | +$97.1K |
2026 Q1
1 quarter
|
|
2588
PUT
Travelers Companies
TRV
$81B
| $330K | ﹤0.01% |
+1,000
| New | +$303K |
2026 Q2
0 quarters
|
|
2589
PUT
Mondelez International
MDLZ
$82.4B
| $330K | ﹤0.01% |
5,700
-10,200
| -64% | -$615K |
2026 Q1
1 quarter
|
|
2590
CALL
Li Auto
LI
$10.9B
| $328K | ﹤0.01% |
27,900
-3,800
| -12% | -$62.3K |
2025 Q2
4 quarters
|
|
2591
PUT
Nice
NICE
$6.1B
| $327K | ﹤0.01% |
+3,600
| New | +$349K |
2026 Q2
0 quarters
|
|
2592
Virgin Galactic
SPCE
$379M
| $327K | ﹤0.01% |
113,098
-125,997
| -53% | -$412K |
2024 Q3
7 quarters
|
|
2593
CALL
United Therapeutics
UTHR
$25.8B
| $325K | ﹤0.01% |
+600
| New | +$338K |
2026 Q2
0 quarters
|
|
2594
Shenandoah Telecom
SHEN
$554M
| $325K | ﹤0.01% |
21,558
+3,550
| +20% | +$55.9K |
2026 Q1
1 quarter
|
|
2595
Warby Parker
WRBY
$2.71B
| $324K | ﹤0.01% |
+10,692
| New | +$265K |
2026 Q2
0 quarters
|
|
2596
Align Technology
ALGN
$10.8B
| $322K | ﹤0.01% |
1,912
-688
| -26% | -$119K |
2025 Q4
2 quarters
|
|
2597
Rocket Pharmaceuticals
RCKT
$276M
| $322K | ﹤0.01% |
94,264
-164,743
| -64% | -$548K |
2025 Q1
5 quarters
|
|
2598
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
| $322K | ﹤0.01% |
+1,469
| New | +$308K |
2026 Q2
0 quarters
|
|
2599
Cooper-Standard Automotive
CPS
$365M
| $322K | ﹤0.01% |
11,892
-699
| -6% | -$20.6K |
2026 Q1
1 quarter
|
|
2600
CALL
T. Rowe Price
TROW
$22.7B
| $318K | ﹤0.01% |
+2,800
| New | +$286K |
2026 Q2
0 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.